Pfizer on Monday urged a U.S. appeals court not to revisit its decision to bar an anti-affirmative action group's challenge ...

Shares of Pfizer Inc. PFE advanced 1.26% to $28.05 Friday, on what proved to be an all-around great trading session for the ...

Pfizer PFE stock has been reeling under the pressure of a declining top line due to a steep drop in revenues from its ...

Pfizer Inc. expects to inform employees of a “transition plan” at a facility in Sanford, the company said Wednesday, weeks ...

Novartis, Pfizer, Novo Nordisk, and Otsuka Pharmaceutical were scolded by a U.K. industry group for violating a voluntary ...

Pfizer's valuation looks attractive, but that doesn't mean the stock is a lock to outperform the broader market.

Pfizer and Moderna's legal battle over their rival COVID-19 vaccines looks set to continue after London's High Court gave a ...

Pfizer is certainly not a high-growth business, but has a high dividend yield and cheap stock price. Learn why PFE stock is a ...

The findings add to research showing vaccination during pregnancy is safe and effective amid growing evidence of severe risks ...

Pfizer has hired a new oncology commercialization leader to help the business reach its goal of marketing eight blockbuster ...

Pfizer shares have suffered a painful slide as pandemic revenue dried up. But management is committed to maintaining and ...

Our analysis of options history for Pfizer PFE revealed 8 unusual trades. Delving into the details, we found 37% of traders ...